HLA-F |
HLA-F, HLA-5.4, HLAF: HLA class I histocompatibility antigen, alpha chain F prec |
B2M |
B2M, CDABP0092, HDCMA22P: Beta-2-microglobulin precursor [Contains: Beta-2-micro |
2.52 |
Evidence |
O
|
HPR |
HPR: Haptoglobin-related protein precursor |
SERPINA6 |
SERPINA6, CBG: Corticosteroid-binding globulin precursor |
2.52 |
Evidence |
|
HLA-DPA1 |
HLA-DPA1, HLA-DP1A, HLASB: HLA class II histocompatibility antigen, DP alpha cha |
HLA-DPB1 |
HLA-DPB1: MHC class II lymphocyte antigen beta chain precursor |
2.52 |
Evidence |
O
|
SNRPB |
SNRPB, COD, SNRPB1: Small nuclear ribonucleoprotein-associated proteins B and B' |
SNRPD1 |
SNRPD1: Small nuclear ribonucleoprotein Sm D1 |
2.52 |
Evidence |
|
MMP1 |
MMP1, CLG: Interstitial collagenase precursor |
TNFAIP6 |
TNFAIP6, TSG6: Tumor necrosis factor-inducible protein TSG-6 precursor |
2.52 |
Evidence |
|
BIRC1 |
BIRC1, NAIP: Baculoviral IAP repeat-containing protein 1 |
CARD15 |
NOD2, CARD15, IBD1: Nucleotide-binding oligomerization domain-containing protein |
2.52 |
Evidence |
|
HLA-DQA1 |
HLA-DQA1: HLA class II histocompatibility antigen, DQ(5) alpha chain precursor |
HLA-DQB1 |
HLA-DQB, HLA-DRB1: HLA class II histocompatibility antigen, DQ(1) beta chain pre |
2.52 |
Evidence |
|
PSMA1 |
PSMA1, PROS30, PSC2: Proteasome subunit alpha type-1 |
PSMB2 |
PSMB2: Proteasome subunit beta type-2 |
2.52 |
Evidence |
|
TCF21 |
TCF21, POD1: Transcription factor 21 |
EPAS1 |
EPAS1, HIF2A, MOP2: Endothelial PAS domain-containing protein 1 |
2.52 |
Evidence |
|
SNRPB |
SNRPB, COD, SNRPB1: Small nuclear ribonucleoprotein-associated proteins B and B' |
LSM5 |
LSM5: U6 snRNA-associated Sm-like protein LSm5 |
2.52 |
Evidence |
|
SNRPB |
SNRPB, COD, SNRPB1: Small nuclear ribonucleoprotein-associated proteins B and B' |
SNRPE |
SNRPE: Small nuclear ribonucleoprotein E |
2.52 |
Evidence |
|
JAK1 |
|
MATK |
DKFZp434N1212, MATK, hCG_23522: Putative uncharacterized protein DKFZp434N1212 |
2.52 |
Evidence |
|
HLA-DQA1 |
HLA-DQA1: HLA class II histocompatibility antigen, DQ(5) alpha chain precursor |
HLA-DMA |
DMA, HLA-DMA, DAQB-96B10.1-001, DASS-67H14.8-001, XXbac-BCX136A3.1-001, XXbac-BP |
2.52 |
Evidence |
|
HLA-F |
HLA-F, HLA-5.4, HLAF: HLA class I histocompatibility antigen, alpha chain F prec |
TAPBPL |
TAPBPL: Tapasin-related protein precursor |
2.52 |
Evidence |
|
SERPINA1 |
SERPINA1, AAT, PRO0684, PI, PRO2209: Alpha-1-antitrypsin precursor |
HABP2 |
HABP2, HGFAL, PHBP: Hyaluronan-binding protein 2 precursor |
2.52 |
Evidence |
|
TNFRSF1B |
TNFRSF1B, TNFBR, TNFR2: Tumor necrosis factor receptor superfamily member 1B pre |
TNFSF10 |
TNFSF10: Uncharacterized protein TNFSF10 |
2.52 |
Evidence |
|
SNRPB |
SNRPB, COD, SNRPB1: Small nuclear ribonucleoprotein-associated proteins B and B' |
SNRPD2 |
SNRPD2, SNRPD1: Small nuclear ribonucleoprotein Sm D2 |
2.52 |
Evidence |
|
HLA-A |
HLA-A, HLAA: HLA class I histocompatibility antigen, A-3 alpha chain precursor |
TAPBPL |
TAPBPL: Tapasin-related protein precursor |
2.52 |
Evidence |
|
OLIG2 |
OLIG2, BHLHB1, PRKCBP2, RACK17: Oligodendrocyte transcription factor 2 |
ARNT2 |
ARNT2, KIAA0307: Aryl hydrocarbon receptor nuclear translocator 2 |
2.52 |
Evidence |
|
SERPINE1 |
SERPINE1, PAI1, PLANH1: Plasminogen activator inhibitor 1 precursor |
GGCX |
GGCX, GC: Vitamin K-dependent gamma-carboxylase |
2.515 |
Evidence |
|
SERPINF1 |
SERPINF1, PEDF: Pigment epithelium-derived factor precursor |
GGCX |
GGCX, GC: Vitamin K-dependent gamma-carboxylase |
2.515 |
Evidence |
|
GP1BA |
IPI00011255 |
GGCX |
GGCX, GC: Vitamin K-dependent gamma-carboxylase |
2.515 |
Evidence |
|
GGCX |
GGCX, GC: Vitamin K-dependent gamma-carboxylase |
ANGPTL3 |
ANGPTL3, ANGPT5, UNQ153/PRO179: Angiopoietin-related protein 3 precursor |
2.515 |
Evidence |
|
RNASE2 |
RNASE2, EDN, RNS2: Non-secretory ribonuclease precursor |
GGCX |
GGCX, GC: Vitamin K-dependent gamma-carboxylase |
2.515 |
Evidence |
|
F2R |
F2R, CF2R, PAR1, TR: Proteinase-activated receptor 1 precursor |
GGCX |
GGCX, GC: Vitamin K-dependent gamma-carboxylase |
2.515 |
Evidence |
|